Downs, R W <br/><br/>
Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass.  [electronic resource] 

 -  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA  Jul 2010 
 - 1215-26 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1433-2965 
<br/><br/><label>Standard No.: </label>10.1007/s00198-009-1060-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers--blood<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--administration & dosage<br/>Bone Remodeling--drug effects<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Endometrium--drug effects<br/>Female<br/>Humans<br/>Lipids--blood<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--blood<br/>Piperidines--administration & dosage<br/>Raloxifene Hydrochloride--therapeutic use<br/>Selective Estrogen Receptor Modulators--administration & dosage<br/>Thiophenes--administration & dosage<br/>Vasomotor System--drug effects